Anna Schwickart
Head of CMC & Preclinical Project Management
clinical
Rigontec
Germany
Biography
Ms. Anna Schwickart is the Co-founder and Head of CMC & Preclinical Project Management at Rigontec GmbH. Ms. Schwickart was involved in the pharmaceutical formulation of immunostimulatory oligonucleotides for preclinical use in cancer therapy, which included Rigontec’s lead candidate. Ms. Schwickart worked as a PhD student at the Institute for Clinical Chemistry and Clinical Pharmacology at the University of Bonn
Research Interest
Clinical Chemistry
